Balboa Research

La Jolla, California 92037

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Hyperkalemia

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia — Completed